Discovering breakthroughs in fibrosis and neurodegeneration

Blade Clinical Trials

Today, we are advancing a differentiated pipeline of oral, small-molecule therapies that include a non-competitive autotaxin inhibitor and multiple inhibitors of dimeric calpains for the potential treatment of lung, liver and cardiac fibrosis or neurodegenerative diseases.

Find Clinical Trials Near Me

Study Description Study Phase Status Trial number
BLD-0409-101 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Phase 1 Complete NCT04146805
BLD-0409-102 Relative Bioavailability Phase 1 In Process NCT04814472
BLD-0409-103 Drug-Drug Interaction with Probe Substrates for CYP450 Enzymes Phase 1 In Process NCT04814498
BLD-0409-104 Drug-Drug Interaction with Approved Therapies for IPF Phase 1 Planned NCT04939467
BLD-0409-203 Idiopathic Pulmonary Fibrosis Phase 2 Planned